Death of cultured human neuroblastoma cells induced by HIV-1 gp120 is prevented by NMDA receptor antagonists and inhibitors of nitric oxide and cyclooxygenase
- 1 September 1995
- journal article
- Published by Elsevier in Neurodegeneration
- Vol. 4 (3) , 315-321
- https://doi.org/10.1016/1055-8330(95)90021-7
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- excessive formation of nitric oxide in CHP100 neuroblastoma cells produces death of BMEL melanoma cells in co-cultureNeuropharmacology, 1994
- Evidence that CHP100 neuroblastoma cell death induced by N-methyl-d-aspartate involves l-arginine-nitric oxide pathway activationNeuroscience Letters, 1992
- Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease.The Journal of Experimental Medicine, 1992
- Models of neuronal injury in AIDS: another role for the NMDA receptor?Trends in Neurosciences, 1992
- Localization of nitric oxide synthase indicating a neural role for nitric oxideNature, 1990
- HIV-1 Coat Protein Neurotoxicity Prevented by Calcium Channel AntagonistsScience, 1990
- CGP 37849 and CGP 39551: novel and potent competitive N‐methyl‐d‐aspartate receptor antagonists with oral activityBritish Journal of Pharmacology, 1990
- Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptideNature, 1988
- Quinoxalinediones: Potent Competitive Non-NMDA Glutamate Receptor AntagonistsScience, 1988
- Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclaseEuropean Journal of Pharmacology, 1987